BioSpace News Archive

Mölnlycke is celebrating World Handwashing Day with the launch of the innovative Biogel ® PI UltraTouch ® S surgical glove, which addresses the problem of allergic contact dermatitis among surgical teams. Frequent handwashing and exposure to chemicals all contribute to occupational contact dermatitis. Exposure to chemical additi

-- The free, one-hour webinar will evaluate electrical power trends and issues at pharmaceutical facilities -- Participants will hear insights into infrastructure design, sustainability, and digitization -- Attendees earn professional education credits

Ablexis, LLC, a biopharmaceutical company focused on licensing its transgenic mouse platforms for antibody drug discovery, today announced further expansion of its intellectual property portfolio directed to its AlivaMab Mouse platform

Abiomed (NASDAQ: ABMD) announces new PROTECT III study data that demonstrates reduced rates of MACCE (composite of death, stroke, myocardial infarction and repeat procedures) when Impella is used to achieve a more complete revascularization in a single setting for high-risk percutaneous coronary intervention (PCI) patients. PROTECT III is an ongoing, prospective, single-arm FDA post-approval study for the PMA approval

Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The worldwide competition, held by R&D World , recognizes R&D pioneers and their revolutionary contributions to science an

Curi —the premier provider of products, services, and experiences for physicians—today announced the appointment of Jason Sandner as its next Chief Executive Officer. Sandner will take the helm on July 1, 2021 , when current CEO Dale Jenkins steps down after more than 25 years of service to the member-owned company. Jenkins wi

Tenax gains developmental and commercial rights for a fully-developed oral levosimendan formulation in the U.S. and Canada Oral formulation expected to be used in upcoming Phase 3 registration trial

BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been included in the 32nd annual Growth List, the definitive ranking of Canada’s Fastest-Growing Companies by Canadian Business and Maclean’s.

Retinal implants are biomedical microchips designed to provide visual perception to people who have lost vision owing to degenerative eye diseases such as retinitis pigmentosa and age-related macular degeneration.

BioInvent International AB announce that they will be presenting a poster on BI-1808, an antibody to tumor necrosis factor receptor 2, at the Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting.